FindTrial
Sign In

Cohort study of cardiovascular disease risk assessment in offspring of polycystic ovary syndrome

Cohort study of cardiovascular disease risk assessment in offspring of polycystic ovary syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100049373
Enrollment
Unknown
Registered
2021-08-01
Start date
2021-10-01
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovarian syndrome

Interventions

Offspring of women with hyperandrogenemia group:None
Offspring of women without hyperandrogenemia group:None

Sponsors

Obstetrics and Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 17 Years

Inclusion criteria

Inclusion criteria: 1.Polycystic ovary syndrome or normal female offspring aged 3 to 17 years; 2.Men and women; 3.Have lived in Shanghai for more than 2 years.

Exclusion criteria

Exclusion criteria: 1.Persons with basic diseases (such as endocrine, cardiovascular and other related diseases) or physical disabilities, motor disorders, intellectual disabilities, language disorders and other disabilities who cannot cooperate with the completion of the survey; 2.Patients with acute disease or have suffered from high fever, diarrhea and other acute inflammatory diseases within the past 1 month.

Design outcomes

Primary

MeasureTime frame
Carotid Intima-media Thickness;—

Secondary

MeasureTime frame
Height, weight, body composition, intelligence tests;—

Countries

China

Contacts

Public ContactGao Ling

Obstetrics and Gynecology Hospital of Fudan University

gaoling@fudan.edu.cn+86 21 64070434 25517

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026